EP3500659A1 - Bioréacteur utilisant des ondes stationnaires acoustiques - Google Patents

Bioréacteur utilisant des ondes stationnaires acoustiques

Info

Publication number
EP3500659A1
EP3500659A1 EP16754152.3A EP16754152A EP3500659A1 EP 3500659 A1 EP3500659 A1 EP 3500659A1 EP 16754152 A EP16754152 A EP 16754152A EP 3500659 A1 EP3500659 A1 EP 3500659A1
Authority
EP
European Patent Office
Prior art keywords
cells
bioreactor
standing wave
flow chamber
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16754152.3A
Other languages
German (de)
English (en)
Inventor
Bart Lipkens
Louis Masi
Iii Stanley Kowalski
Jr. Walter M. Presz
Jason Dionne
Brian DUTRA
Ari MERCADO
Iii Thomas J. Kennedy
Arthur Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flodesign Sonics Inc
Original Assignee
Flodesign Sonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flodesign Sonics Inc filed Critical Flodesign Sonics Inc
Publication of EP3500659A1 publication Critical patent/EP3500659A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/28—Mechanical auxiliary equipment for acceleration of sedimentation, e.g. by vibrators or the like
    • B01D21/283—Settling tanks provided with vibrators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/14—Bags
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion

Definitions

  • bioreactor One of the key components that is utilized in the manufacturing processes of new biologically based pharmaceuticals is the bioreactor and the ancillary processes associated therewith.
  • An area of growth in the bioreactor field has been with the perfusion process.
  • the perfusion process is distinguished from the fed-batch process by its lower capital cost and higher throughput.
  • a culture is seeded in a bioreactor.
  • the gradual addition of a fresh volume of selected nutrients during the growth cycle is used to improve productivity and growth.
  • the product is recovered after the culture is harvested.
  • the fed batch bioreactor process has been attractive because of its simplicity and also due to carryover from well-known fermentation processes.
  • a fed-batch bioreactor has high start-up costs, and generally has a large volume to obtain a cost- effective amount of product at the end of the growth cycle.
  • the bioreactor must be cleaned and sterilized, resulting in nonproductive downtime.
  • a perfusion bioreactor processes a continuous supply of fresh media that is fed into the bioreactor while growth-inhibiting byproducts are constantly removed. The nonproductive downtime can be reduced or eliminated with a perfusion bioreactor process.
  • the cell densities achieved in perfusion culture (30-100 million cells/mL) are typically higher than for fed-batch modes (5-25 million cells/mL).
  • a perfusion bioreactor requires a cell retention device to prevent escape of the culture when byproducts are being removed.
  • These cell retention systems add a level of complexity to the perfusion process, requiring management, control, and maintenance for successful operation. Operational issues such as malfunction or failure of the cell retention equipment has previously been a problem with perfusion bioreactors. This has limited their attractiveness in the past.
  • the present disclosure relates, in various embodiments, to a system for producing biomolecules such as recombinant proteins or monoclonal antibodies, and for separating these desirable products from a cell culture in a bioreactor.
  • a fluid medium containing the cells and the desired products are passed or flowed through a filtering device.
  • the present disclosure also relates, in various other embodiments, to a system for generating cells.
  • such generated cells may be for use in a cell therapy process.
  • the desired cells e.g., T cells, B cells, or NK cells
  • the host fluid is then flowed through a filtering device to capture some of the cells, while the remaining cells continue to be cultured in the bioreactor.
  • the cells are plant cells used for bio-agriculture techniques, for example in the production of phytochemicals or insect resistant plants.
  • a system comprising a bioreactor and a filtering device.
  • the bioreactor includes a reaction vessel, an agitator, a feed inlet, and an outlet.
  • the filtering device comprises: an inlet fluidly connected to the bioreactor outlet for receiving fluid from the bioreactor; a flow chamber through which the fluid can flow; and at least one ultrasonic transducer and a reflector located opposite the at least one ultrasonic transducer, the at least one ultrasonic transducer being driven to produce a multi-dimensional standing wave in the flow chamber.
  • the filtering or trapping device for the bioreactor may also consist of a flow chamber with one or more ultrasonic transducers and reflectors incorporated into the flow chamber.
  • the reflectors are set up opposite the ultrasonic transducers and the ultrasonic transducers are electronically driven to form a multi-dimensional acoustic standing wave in the flow chamber.
  • the flow chamber may be made from a rigid material, such as a plastic, glass or metal container.
  • the flow chamber may alternatively be in the form of a flexible polymeric bag or pouch that is capable of being sealed and removed from the recirculation path between the bioreactor outlet through the external filtering device and a recycle inlet of the bioreactor.
  • This flexible polymeric bag or pouch may be located between an ultrasonic transducer and a reflector such that a multi-dimensional acoustic standing wave may be generated interior to the flexible polymeric bag or pouch.
  • the filtering device may further comprise a product outlet through which desired product, such as expanded cells, viruses, exosomes, or phytochemicals are recovered.
  • desired product such as expanded cells, viruses, exosomes, or phytochemicals are recovered.
  • the filtering device can also further comprise a recycle outlet for sending fluid back to the bioreactor.
  • the multi-dimensional standing wave may have an axial force component and a lateral force component which are of the same order of magnitude.
  • the bioreactor can be operated as a perfusion bioreactor.
  • the sleeve may be separable from the flow chamber.
  • the filtering device further comprises a jacket located between the sleeve and the flow chamber, the jacket being used to regulate the temperature of the fluid in the flow chamber.
  • the jacket, the sleeve, and the flow chamber can be separable from each other and be disposable.
  • the ultrasonic transducer comprises a piezoelectric material that can vibrate in a higher order mode shape.
  • the piezoelectric material may have a rectangular shape.
  • the ultrasonic transducer may comprise: a housing having a top end, a bottom end, and an interior volume; and a crystal at the bottom end of the housing having an exposed exterior surface and an interior surface, the crystal being able to vibrate when driven by a voltage signal.
  • a backing layer contacts the interior surface of the crystal, the backing layer being made of a substantially acoustically transparent material.
  • the substantially acoustically transparent material can be balsa wood, cork, or foam.
  • the substantially acoustically transparent material may have a thickness of up to 1 inch.
  • the substantially acoustically transparent material can be in the form of a lattice.
  • an exterior surface of the crystal is covered by a wear surface material with a thickness of a half wavelength or less, the wear surface material being a urethane, epoxy, or silicone coating.
  • the crystal has no backing layer or wear layer.
  • the ultrasonic transducer may also comprise a piezoelectric material that is polymeric such as polyvinylidene fluoride (PVDF).
  • PVDF polyvinylidene fluoride
  • the PVDF may be excited at higher frequencies up to the hundreds of megahertz range such that very small particles may be trapped by the acoustic standing wave.
  • the multi-dimensional standing wave can be a three-dimensional standing wave.
  • the reflector may have a non-planar surface.
  • the product outlet of the filtering device may lead to a further process such as cell washing, cell concentration or cell fractionation.
  • Such processes may be applied when the recovered product is biological cells such as T cells, B cells and NK cells.
  • the cells used to produce viruses or exosomes are Chinese hamster ovary (CHO) cells, NS0 hybridoma cells, baby hamster kidney (BHK) cells, or human cells.
  • CHO Chinese hamster ovary
  • NS0 hybridoma cells NS0 hybridoma cells
  • BHK baby hamster kidney
  • human cells are plant cells that produce secondary metabolites and recombinant proteins and other phytochemicals.
  • Figure 1 illustrates a single standing acoustic wave generated by an ultrasonic transducer and a reflector.
  • Figure 2 is an illustration comparing a fed-batch bioreactor system with a perfusion bioreactor system.
  • Figure 3 is a cross-sectional view that shows the various components of a bioreactor.
  • Figure 4 shows one embodiment of an acoustophoretic filtering device of the present disclosure, with a sleeve surrounding a pipe that acts as a flow chamber and is disposable.
  • Figure 5 shows another embodiment of an acoustophoretic filtering device of the present disclosure, showing a jacket surrounding the flow chamber, and the sleeve surrounding the jacket.
  • the sleeve contains a fluid that is used to regulate the temperature of the fluid passing through the flow chamber.
  • Figure 6 is a schematic view illustrating a system of the present disclosure, including a perfusion bioreactor with an acoustophoretic separation device, and a recycle path.
  • Figure 7 is a cross-sectional diagram of a conventional ultrasonic transducer.
  • Figure 8 is a picture of a wear plate of a conventional transducer.
  • Figure 9 is a cross-sectional diagram of an ultrasonic transducer of the present disclosure. An air gap is present within the transducer, and no backing layer or wear plate is present.
  • Figure 10 is a cross-sectional diagram of an ultrasonic transducer of the present disclosure. An air gap is present within the transducer, and a backing layer and wear plate are present.
  • Figure 11 is a graph of electrical impedance amplitude versus frequency for a square transducer driven at different frequencies.
  • Figure 12 illustrates the trapping line configurations for seven of the peak amplitudes of Figure 11 from the direction orthogonal to fluid flow.
  • Figure 13 is a computer simulation of the acoustic pressure amplitude (right- hand scale in Pa) and transducer out of plane displacement (left-hand scale in meters).
  • the text at the top of the left-hand scale reads "x10 "7 ".
  • the text at the top of the left- hand scale by the upward-pointing triangle reads "1.473x10 "6 ".
  • the text at the bottom of the left-hand scale by the downward-pointing triangle reads "1.4612x10 "10 ".
  • the text at the top of the right-hand scale reads "x10 6 ".
  • the text at the top of the right-hand scale by the upward-pointing triangle reads .1 129x10 6 ".
  • the text at the bottom of the right- hand scale by the downward-pointing triangle reads "7.357".
  • the triangles show the maximum and minimum values depicted in this figure for the given scale.
  • the horizontal axis is the location within the chamber along the X-axis, in inches
  • the vertical axis is the location within the chamber along the Y-axis, in inches.
  • Figure 14 shows the In-Plane and Out-of-Plane displacement of a crystal where composite waves are present.
  • Figure 15 shows an exploded view of an acoustophoretic separator used for conducting some example separations, having one flow chamber.
  • Figure 16 shows an exploded view of a stacked acoustophoretic separator with two flow chambers.
  • Figure 17 is a graph showing the efficiency of removing cells from a medium using a Beckman Coulter Cell Viability Analyzer for one experiment.
  • Figure 18 is a graph showing the efficiency of removing cells from a medium using a Beckman Coulter Cell Viability Analyzer for another experiment.
  • Figure 19 is an illustration of an embodiment where the filtering device is in the form of a flexible bag.
  • the terms “upper” and “lower” are relative to each other in location, i.e. an upper component is located at a higher elevation than a lower component in a given orientation, but these terms can change if the device is flipped.
  • the terms “inlet” and “outlet” are relative to a fluid flowing through them with respect to a given structure, e.g. a fluid flows through the inlet into the structure and flows through the outlet out of the structure.
  • upstream and “downstream” are relative to the direction in which a fluid flows through various components, i.e. the flow fluids through an upstream component prior to flowing through the downstream component. It should be noted that in a loop, a first component can be described as being both upstream of and downstream of a second component.
  • the present application refers to "the same order of magnitude.” Two numbers are of the same order of magnitude if the quotient of the larger number divided by the smaller number is a value of at least 1 and less than 10.
  • virus refers to an infectious agent that can only replicate inside another living cell, and otherwise exists in the form of a virion formed from a capsid that surrounds and contains DNA or RNA, and in some cases a lipid envelope surrounding the capsid.
  • exosome refers to a vesicle, which has a lipid bilayer surrounding a core of fluid that contains proteins, DNA, and/or RNA.
  • crystal refers to a single crystal or polycrystalline material that is used as a piezoelectric material.
  • Bioreactors are useful for making biomolecules such as recombinant proteins or monoclonal antibodies.
  • cells are cultured in a bioreactor vessel with media in order to produce the desired product, and the desired product is then harvested by separation from the cells and media.
  • mammalian cell cultures including Chinese hamster ovary (CHO), NS0 hybridoma cells, baby hamster kidney (BHK) cells, and human cells has proven to be a very efficacious way of producing/expressing the recombinant proteins and monoclonal antibodies used in pharmaceuticals.
  • the perfusion process can now be scaled up to bioreactors having a volume up to 1000 liters (L). Better cell retention systems for perfusion bioreactors result in lower cell loss and greater cell densities than have been seen previously. Cell densities greater than 50 million cells/mL are now achievable, compared to fed-batch cell densities of around 20 million cells/mL. Lower contamination and infection rates have improved the output of perfusion bioreactors. Higher product concentrations in the harvest and better yields without significant increase in cost have thus resulted for perfusion processes.
  • a separate aspect of the use of high cell concentration bioreactors is the "dewatering" of the materials at the end of a bioreactor run.
  • the "dewatering" or removal of interstitial fluid from a bioreactor sludge is important for improving the efficiency of recovery of the intended bioreactor product.
  • high energy centrifuges with internal structures are utilized to remove the interstitial fluid from the bioreactor sludge at the end of a run.
  • the capital cost and operating costs for a disk stack centrifuge is high.
  • a simpler method of removing the interstitial fluid from the remaining bioreactor sludge that can be performed without the high capital and operating costs associated with disk stack centrifuges is desirable.
  • current methods of filtration or centrifugation can damage cells, releasing protein debris and enzymes into the purification process and increasing the load on downstream portions of the purification system.
  • the present disclosure relates to the generation of multi-dimensional (e.g., three-dimensional (3-D)) acoustic standing wave(s) from one or more piezoelectric transducers, where the transducers are electrically or mechanically excited such that they move in a "drumhead” or multi-excitation mode (i.e., multi-mode displacement pattern), rather than a "piston” or single excitation mode fashion.
  • multi-dimensional e.g., three-dimensional (3-D)
  • multi-excitation mode i.e., multi-mode displacement pattern
  • the multi-dimensional (e.g., 3-D) acoustic standing wave(s) can have a higher lateral trapping force compared to a single planar acoustic standing wave.
  • the input power is tunable for a controlled flow. This can be used to facilitate proteinaceous fluid purification of the contents of a bioreactor.
  • the present disclosure relates to processing systems comprising a bioreactor and a filtering device, the filtering device using acoustophoresis for separation of various components.
  • an acoustophoretic filtering device that incorporates a multi-dimensional (e.g., 3-D) standing wave
  • maintaining flux rates and minimizing cross-contamination risk in a multiproduct system can also be achieved.
  • Other benefits such as cleaning procedures and related demands often detailed and validated within standard operating procedures (SOP), can also be realized through the use of a multidimensional (e.g., 3-D) acoustic standing wave capable apparatus.
  • SOP standard operating procedures
  • Acoustophoresis is a low-power, no-pressure-drop, no-clog, solid-state approach to particle removal from fluid dispersions: i.e., it is used to achieve separations that are more typically performed with porous filters, but it has none of the disadvantages of filters.
  • the present disclosure provides filtering devices that are suitable for use with bioreactors and operate at the macro-scale for separations in flowing systems with high flow rates.
  • the acoustophoretic filtering device is designed to create a high intensity multi-dimensional (e.g., three dimensional) ultrasonic standing wave that results in an acoustic radiation force that is larger than and can overcome the combined effects of fluid drag and buoyancy or gravity at certain flow rates, and is therefore able to trap (i.e., hold stationary) the suspended phase (i.e. cells) to allow more time for the acoustic wave to increase particle concentration, agglomeration and/or coalescence.
  • the radiation force of the acoustic standing wave(s) acts as a filter that prevents or retards targeted particles (e.g., biological cells) from crossing through the standing wave(s).
  • the present systems have the ability to create ultrasonic standing wave fields that can trap particles in flow fields with a linear velocity ranging from 0.1 mm/sec to velocities exceeding 1 cm/s.
  • the trapping capability of a standing wave may be varied as desired, for example by varying the flow rate of the fluid, the acoustic radiation force, and the shape of the acoustic filtering device to maximize cell retention through trapping and settling.
  • This technology offers a green and sustainable alternative for separation of secondary phases with a significant reduction in cost of energy. Excellent particle separation efficiencies have been demonstrated for particle sizes as small as one micron.
  • the ultrasonic standing waves can be used to trap, i.e., hold stationary, secondary phase particles (e.g. cells) in a host fluid stream (e.g. cell culture media).
  • secondary phase particles e.g. cells
  • a host fluid stream e.g. cell culture media.
  • the scattering of the acoustic field off the particles results in a three dimensional acoustic radiation force, which acts as a three-dimensional trapping field.
  • the acoustic radiation force is proportional to the particle volume (e.g. the cube of the radius) when the particle is small relative to the wavelength. It is proportional to frequency and the acoustic contrast factor. It also scales with acoustic energy (e.g.
  • the sinusoidal spatial variation of the force is what drives the particles to the stable positions within the standing waves.
  • the acoustic radiation force exerted on the particles is stronger than the combined effect of fluid drag force and buoyancy/gravitational force, the particle is trapped within the acoustic standing wave field.
  • the action of the acoustic forces (i.e., the lateral and axial acoustic forces) on the trapped particles results in formation of tightly-packed clusters through concentration, clustering, clumping, agglomeration and/or coalescence of particles that, when reaching a critical size, settle continuously through enhanced gravity for particles heavier than the host fluid or rise out through enhanced buoyancy for particles lighter than the host fluid.
  • secondary inter-particle forces such as Bjerkness forces, aid in particle agglomeration.
  • the 3-D standing wave(s) filtering system is operated at a voltage such that the protein-producing materials, such as Chinese hamster ovary cells (CHO cells), the most common host for the industrial production of recombinant protein therapeutics, are trapped in the ultrasonic standing wave, i.e., remain in a stationary position. Within each nodal plane, the CHO cells are trapped in the minima of the acoustic radiation potential. Most biological cell types present a higher density and lower compressibility than the medium in which they are suspended, so that the acoustic contrast factor between the cells and the medium has a positive value. As a result, the axial acoustic radiation force (ARF) drives the biological cells towards the standing wave pressure nodes.
  • the protein-producing materials such as Chinese hamster ovary cells (CHO cells)
  • CHO cells Chinese hamster ovary cells
  • the CHO cells are trapped in the minima of the acoustic radiation potential.
  • Most biological cell types present a higher density and lower compressibility than
  • the axial component of the acoustic radiation force drives the cells, with a positive contrast factor, to the pressure nodal planes, whereas cells or other particles with a negative contrast factor are driven to the pressure anti- nodal planes.
  • the radial or lateral component of the acoustic radiation force is the force that traps the cells.
  • the radial or lateral component of the ARF is larger than the combined effect of fluid drag force and gravitational force.
  • the buoyancy force F is expressed as:
  • p is the acoustic pressure
  • u is the fluid particle velocity
  • ⁇ is the ratio of cell density p p to fluid density p f
  • ⁇ is the ratio of cell sound speed c p to fluid sound speed Cf
  • V 0 is the volume of the cell
  • ⁇ > indicates time averaging over the period of the wave.
  • the lateral force component of the total acoustic radiation force (ARF) generated by the ultrasonic transducer(s) of the present disclosure is significant and is sufficient to overcome the fluid drag force at linear velocities of up to 1 cm/s, and to create tightly packed clusters, and is of the same order of magnitude as the axial force component of the total acoustic radiation force.
  • This lateral ARF can thus be used to retain cells in a bioreactor while the bioreactor process continues. This is especially true for a perfusion bioreactor.
  • the filtering devices of the present disclosure which use ultrasonic transducers and acoustophoresis, can also improve the dewatering of the leftover material from a bioreactor batch (i.e bioreactor sludge), and thus reduce the use of or eliminate the use of disk stack centrifuges. This use or application of ultrasonic transducers and acoustophoresis simplifies processing and reduces costs.
  • a perfusion bioreactor system it is desirable to be able to filter and separate the cells and cell debris from the expressed materials that are in the fluid stream (i.e. cell culture media).
  • the expressed materials are composed of biomolecules such as recombinant proteins or monoclonal antibodies, and are the desired product to be recovered.
  • An acoustophoretic filtering device can be used in at least two different ways.
  • the standing waves can be used to trap the expressed biomolecules and separate this desired product from the cells, cell debris, and media.
  • the expressed biomolecules can then be diverted and collected for further processing.
  • the standing waves can be used to trap the cells and cell debris present in the cell culture media.
  • the cells and cell debris having a positive contrast factor, move to the nodes (as opposed to the anti-nodes) of the standing wave.
  • the cells and cell debris agglomerate at the nodes of the standing wave, there is also a physical scrubbing of the cell culture media that occurs whereby more cells are trapped as they come in contact with the cells that are already held within the standing wave.
  • the standing wave may be interrupted to allow all of the cells to fall out of the fluid stream that is being filtered. This process can be useful for dewatering.
  • the expressed biomolecules may have been removed beforehand, or remain in the fluid stream (i.e. cell culture medium).
  • the ultrasonic transducer(s) generate a multi-dimensional (e.g., three-dimensional) standing wave in the fluid that exerts a lateral force on the suspended particles to accompany the axial force so as to increase the particle trapping capabilities of the acoustophoretic filtering device.
  • a multi-dimensional standing wave in the fluid that exerts a lateral force on the suspended particles to accompany the axial force so as to increase the particle trapping capabilities of the acoustophoretic filtering device.
  • Typical results published in literature state that the lateral force is two orders of magnitude smaller than the axial force.
  • the technology disclosed in this application provides for a lateral force to be of the same order of magnitude as the axial force.
  • a perfusion bioreactor can also be used to generate cells that can subsequently be used for cell therapy.
  • the biological cells to be used in the cell therapy are cultured in the bioreactor and expanded (i.e. to increase the number of cells in the bioreactor through cell reproduction).
  • These cells may be lymphocytes such as T cells (e.g., regulatory T-cells (Tregs), , Jurkat T-cells), B cells, or NK cells; their precursors, such as peripheral blood mononuclear cells (PBMCs); and the like.
  • T cells e.g., regulatory T-cells (Tregs), , Jurkat T-cells), B cells, or NK cells; their precursors, such as peripheral blood mononuclear cells (PBMCs); and the like.
  • the cell culture media aka host fluid
  • a filtering device that produces an acoustic standing wave. A portion of the cells are trapped and held in the acoustic standing wave, while the remaining host fluid and other cells in the host fluid are returned to the bioreactor.
  • the clusters can fall into a product outlet outside a region of the acoustic standing wave, such as below the acoustic standing wave, from which the cells can be recovered for use in cell therapy. Only a small portion of the cells are trapped and removed from the bioreactor via the product outlet, and the remainder continue to reproduce in the bioreactor, allowing for continuous production and recovery of the desired cells.
  • acoustic standing waves are used to trap and hold biological cells and to separate viruses (e.g. lentiviruses) or exosomes that are produced by the biological cells.
  • the biological cells are returned to the bioreactor post-separation to continue production of viruses or exosomes.
  • the acoustic filtering devices of the present disclosure can act as a cell retention device.
  • the acoustic cell retention systems described herein operate over a range of cell recirculation rates, efficiently retain cells over a range of perfusion (or media removal) rates, and can be tuned to fully retain or selectively pass some percentage of cells through fluid flow rate, transducer power or frequency manipulation. Power and flow rates can all be monitored and used as feedback in an automated control system.
  • the cells of interest may also be held in the flow chamber of the external filtering device through the use of an acoustic standing wave such that other moieties may be introduced in close proximity to and for the purpose of changing the target cells.
  • Such an operation would include the trapping of T cells and the subsequent introduction of modified lentivirus materials with a specific gene splice such that the lentivirus with a specific gene splice will transfect the T cell and generate a chimeric antigen receptor T cell also known as a CAR-T cell.
  • the acoustic filtering devices of the present disclosure are designed to maintain a high intensity three-dimensional acoustic standing wave.
  • the device is driven by a function generator and amplifier (not shown).
  • the device performance is monitored and controlled by a computer. It may be desirable, at times, due to acoustic streaming, to modulate the frequency or voltage amplitude of the standing wave. This modulation may be done by amplitude modulation and/or by frequency modulation.
  • the duty cycle of the propagation of the standing wave may also be utilized to achieve certain results for trapping of materials. In other words, the acoustic beam may be turned on and shut off at different frequencies to achieve desired results.
  • FIG. 1 illustrates a single standing wave system 100 that is comprised of a reflector plate 101 and an ultrasonic transducer 103 that is set to resonate so as to form a standing wave 102.
  • Excitation frequencies typically in the range from hundreds of kHz to tens of MHz are applied by the transducer 103.
  • One or more standing waves are created between the transducer 103 and the reflector 101.
  • the standing wave is the sum of two propagating waves that are equal in frequency and intensity and that are traveling in opposite directions, i.e. from the transducer to the reflector and back.
  • the propagating waves destructively interfere with each other and thus generate the standing wave.
  • a dotted line 105 is used to indicate the amplitude.
  • a node is a point where the wave has minimum amplitude, and is indicated with reference numeral 107.
  • An anti-node is a point where the wave has maximum amplitude, and is indicated with reference numeral 109.
  • FIG. 2 is a schematic diagram that compares a fed-batch bioreactor system 201 (left side) with a perfusion bioreactor system 202 (right side).
  • the bioreactor 210 includes a reaction vessel 220.
  • the cell culture media is fed to the reaction vessel through a feed inlet 222.
  • An agitator 225 is used to circulate the media throughout the cell culture.
  • the agitator is depicted as a set of rotating blades, though any type of system that causes circulation is contemplated.
  • the bioreactor permits growth of a seed culture through a growth / production cycle, during which time debris, waste and unusable cells will accumulate in the bioreactor and the desired product (e.g.
  • the reaction vessel 220 also includes an outlet 224 for removing material.
  • the bioreactor includes a reaction vessel 220 with a feed inlet 222 for the cell culture media.
  • An agitator 225 is used to circulate the media throughout the cell culture.
  • An outlet 224 of the reaction vessel is fluidly connected to the inlet 232 of a filtering device 230, and continuously feeds the media (containing cells and desired product) to the filtering device.
  • the filtering device 230 is located downstream of the reaction vessel, and separates the desired product from the cells.
  • the filtering device 230 has two separate outlets, a product outlet 234 and a recycle outlet 236.
  • the product outlet 234 fluidly connects the filtering device 230 to a containment vessel 240 downstream of the filtering device, which receives a concentrated flow of the desired product (plus media) from the filtering device. From there, further processing / purification can occur to isolate / recover the desired product.
  • the recycle outlet 236 fluidly connects the filtering device 230 back to a recycle inlet 226 of the reaction vessel 220, and is used to send the cells and cell culture media back into the reaction vessel for continued growth / production. Put another way, there is a fluid loop between the reaction vessel and the filtering device.
  • the reaction vessel 220 in the perfusion bioreactor system 202 has a continuous throughput of product and thus can be made smaller than the fed-batch bioreactor system 201.
  • the filtering process is critical to the throughput of the perfusion bioreactor. A poor filtering process will allow for only low throughput and result in low yields of the desired product.
  • FIG. 3 is a cross-sectional view of a generic bioreactor 300 that is useful for the systems of the present disclosure.
  • the bioreactor includes a reaction vessel 320 having an internal volume 323.
  • a feed inlet 322 at the top of the vessel is used to feed cell culture media into the vessel.
  • An agitator 325 is present.
  • An outlet 324 is shown at the bottom of the vessel.
  • a thermal jacket 310 surrounds the reaction vessel, and is used to regulate the temperature of the cells / media.
  • An aerator 312 is located on the bottom of the vessel for providing gas to the internal volume.
  • Sensors 314 are shown at the top right of the vessel.
  • a pump 316 is illustrated for feeding the cell culture media into the vessel, as is another pump 318 for removing cell culture media from the vessel.
  • An interior light source for illuminating the internal volume may be present, for example when the bioreactor is used for growing plant cells.
  • the perfusion systems of the present disclosure also use an acoustophoretic filtering device.
  • the contents of the bioreactor are continuously flowed through the filtering device to capture the desired products.
  • FIG. 4 is a first embodiment of an acoustophoretic filtering device 400.
  • the device includes a flow chamber 410, which is depicted here as a cylindrical pipe or tube.
  • a feed inlet 412 is illustrated here at the bottom of the flow chamber, through which fluid from the bioreactor is received.
  • An outlet 414 is depicted at the top of the flow chamber, with the arrows (reference numeral 415) indicating the direction of fluid flow.
  • a sleeve 420 surrounds the flow chamber.
  • the sleeve includes at least one ultrasonic transducer 422 and at least one reflector 424, which are located opposite each other.
  • the transducer and reflector generate one or more standing waves 425, with the reflector bouncing the initial propagated wave back towards the transducer with a similar frequency and intensity to form an acoustic standing wave.
  • the sleeve can be separated from the flow chamber / pipe. The pipe can be discarded and replaced with a new pipe. This configuration allows for disposable parts in the filtering device, and thus reduces the cost of cleaning and sterilization that might otherwise be incurred with a permanent filter.
  • the filtering device may include additional inlets or outlets not depicted here, as previously explained.
  • FIG. 5 is a second embodiment of the acoustophoretic filtering device.
  • the filtering device 400 also includes a jacket 430 that is located between the sleeve 420 and the flow chamber 410.
  • the jacket contains a temperature-regulating fluid 432 that can be used to control the temperature of the fluid passing through the flow chamber. In this regard, it is usually desirable to maintain the temperature of the cell culture below 38°C to prevent compromise of the cells.
  • the temperature-regulating fluid is completely separated from the cell culture media/fluid passing through the flow chamber 410. It is noted that the standing wave 425 created by the transducer 422 and reflector 424 will propagate through the jacket 430 and the temperature regulating fluid 432 therein, and will continue to operate in the flow chamber to separate the targeted material in the flow chamber.
  • FIG. 6 illustrates an exemplary processing system of the present disclosure, comprising a bioreactor 610 and a filtering device 630.
  • the system is set up for use as a perfusion bioreactor.
  • the bioreactor 610 includes a reaction vessel 620 having a feed inlet 622, an outlet 624, and a recycle inlet 626. Media is added into the feed inlet 622 by an addition pipe 650.
  • the contents of the reaction vessel (reference numeral 605) are mixed with an agitator 625.
  • the desired product e.g. recombinant proteins, viruses, exosomes, or additional cells
  • the product and the cells in the perfusion bioreactor are drawn from the reaction vessel through pipe 652, and enter the acoustophoretic filtering device 630 through inlet 632.
  • the desired product is separated from the cells through the use of multidimensional standing waves.
  • the desired product can be drawn off through a product outlet 634 and pipe 654 into a containment vessel 640.
  • the cells are returned to the perfusion bioreactor after separation, passing from recycle outlet 636 of the filtering device through pipe 656 to recycle inlet 626 of the reaction vessel, which form a recycle path.
  • the 3-D standing waves of the acoustophoresis device allow for high throughput of the perfusion reactor due to the increased lateral trapping force of the 3-D standing waves. It is noted that although the reaction vessel outlet 624 is depicted at the top of the vessel and the recycle inlet 626 is depicted at the bottom of the vessel, that this arrangement can be reversed if desired. This may depend on the desired product to be obtained.
  • the filtering device 630 is in the form of a flexible bag or pouch. Such a filtering device is illustrated in Figure 19.
  • the interior volume of the flexible bag 700 operates as the flow chamber.
  • the flexible bag includes an inlet 702 and an outlet 704.
  • Opposite surfaces of the flexible bag can be stiff. One surface includes an ultrasonic transducer 710, and the opposite surface includes a reflector 712 opposite the transducer, so that a multidimensional acoustic standing wave can be generated within the bag.
  • cell culture media and cells are drawn from the reaction vessel through pipe 652, and enter the flexible bag 700 through inlet 702.
  • the multi-dimensional acoustic standing wave traps the desired product (i.e. cells).
  • the cell culture media and other material exit through the outlet 704 through pipe 656 back to recycle inlet 626 of the reaction vessel.
  • the fluid flow through the bag 700 is stopped.
  • the bag filled with concentrated cells can then be taken out of the recycle path between the product outlet 634 and the recycle inlet 626 of the reaction vessel.
  • the concentrated cells are then recovered from the bag.
  • a flexible bag or pouch is used within the flow chamber of the filtering device 630 for the capture of cells.
  • This flexible bag or pouch is similar to the bag 700 of Figure 19, but does not have the ultrasonic transducer and reflector attached thereto.
  • Cell culture media and cells are drawn from the reaction vessel through pipe 652, and enter the acoustophoretic filtering device 630 through inlet 632.
  • the flexible bag itself contains an inlet and an outlet, and the acoustophoretic filtering device acts as a housing for the bag.
  • the multidimensional acoustic standing wave traps the desired product (i.e. cells).
  • the cell culture media and other material exit through the outlet of the bag and out through recycle outlet 636 of the filtering device through pipe 656 to recycle inlet 626 of the reaction vessel, which form a recycle path.
  • the filtering device inlet 632 would probably be near the middle of the filtering device 630, and the recycle outlet 636 would probably be located at the top of the filtering device, with the concentrated cells falling to the bottom of the flexible bag to be collected.
  • No product outlet 634 or containment vessel 640 would be needed to collect the product, which would be collected in the flexible bag that is subsequently removed from the flow chamber of the filtering device 630.
  • FIG. 7 is a cross-sectional diagram of a conventional ultrasonic transducer.
  • This transducer has a wear plate 50 at a bottom end, epoxy layer 52, ceramic crystal 54 (made of, e.g. Lead Zirconate Titanate (PZT)), an epoxy layer 56, and a backing layer 58.
  • PZT Lead Zirconate Titanate
  • the epoxy layer 56 attaches backing layer 58 to the crystal 54.
  • the entire assembly is contained in a housing 60 which may be made out of, for example, aluminum.
  • An electrical adapter 62 provides connection for wires to pass through the housing and connect to leads (not shown) which attach to the crystal 54.
  • backing layers are designed to add damping and to create a broadband transducer with uniform displacement across a wide range of frequency and are designed to suppress excitation at particular vibrational eigen-modes.
  • Wear plates are usually designed as impedance transformers to better match the characteristic impedance of the medium into which the transducer radiates.
  • Figure 8 is a photo of a wear plate 50 with a bubble 64 where the wear plate has pulled away from the ceramic crystal surface due to the oscillating pressure and heating.
  • FIG. 9 is a cross-sectional view of an ultrasonic transducer 81 of the present disclosure, which is used in the acoustophoretic filtering devices of the present disclosure.
  • Transducer 81 has an aluminum housing 82.
  • a PZT crystal 86 defines the bottom end of the transducer, and is exposed from the exterior of the housing.
  • the crystal is supported on its perimeter by a small elastic layer 98, e.g. silicone or similar material, located between the crystal and the housing. Put another way, no wear layer is present.
  • a small elastic layer 98 e.g. silicone or similar material
  • Screws attach an aluminum top plate 82a of the housing to the body 82b of the housing via threads 88.
  • the top plate includes a connector 84 to pass power to the PZT crystal 86.
  • the bottom and top surfaces of the PZT crystal 86 are each connected to an electrode (positive and negative), such as silver or nickel.
  • a wrap-around electrode tab 90 connects to the bottom electrode and is isolated from the top electrode. Electrical power is provided to the PZT crystal 86 through the electrodes on the crystal, with the wrap-around tab 90 being the ground connection point. Note that the crystal 86 has no backing layer or epoxy layer as is present in Figure 5.
  • a minimal backing 58 and/or wear plate 50 may be provided in some embodiments, as seen in Figure 10.
  • the transducer design can affect performance of the system.
  • a typical transducer is a layered structure with the ceramic crystal bonded to a backing layer and a wear plate. Because the transducer is loaded with the high mechanical impedance presented by the standing wave, the traditional design guidelines for wear plates, e.g., half wavelength thickness for standing wave applications or quarter wavelength thickness for radiation applications, and manufacturing methods may not be appropriate. Rather, in one embodiment of the present disclosure the transducers, there is no wear plate or backing, allowing the crystal to vibrate in one of its eigenmodes with a high Q-factor. The vibrating ceramic crystal/disk is directly exposed to the fluid flowing through the flow chamber.
  • Removing the backing also permits the ceramic crystal to vibrate at higher order modes of vibration with little damping (e.g. higher order modal displacement).
  • the crystal vibrates with a more uniform displacement, like a piston.
  • Removing the backing allows the crystal to vibrate in a non-uniform displacement mode.
  • the higher order the mode shape of the crystal the more nodal lines the crystal has.
  • the higher order modal displacement of the crystal creates more trapping lines, although the correlation of trapping line to node is not necessarily one to one, and driving the crystal at a higher frequency will not necessarily produce more trapping lines.
  • the crystal may have a backing that minimally affects the Q-factor of the crystal (e.g. less than 5%).
  • the backing may be made of a substantially acoustically transparent material such as balsa wood, foam, or cork which allows the crystal to vibrate in a higher order mode shape and maintains a high Q-factor while still providing some mechanical support for the crystal.
  • the backing layer may be a solid, or may be a lattice having holes through the layer, such that the lattice follows the nodes of the vibrating crystal in a particular higher order vibration mode, providing support at node locations while allowing the rest of the crystal to vibrate freely.
  • the goal of the lattice work or acoustically transparent material is to provide support without lowering the Q-factor of the crystal or interfering with the excitation of a particular mode shape.
  • Placing the crystal in direct contact with the fluid also contributes to the high Q-factor by avoiding the dampening and energy absorption effects of the epoxy layer and the wear plate.
  • Other embodiments may have wear plates or a wear surface to prevent the PZT, which contains lead, contacting the host fluid. This may be desirable in, for example, biological applications such as separating blood. Such applications might use a wear layer such as chrome, electrolytic nickel, or electroless nickel.
  • Chemical vapor deposition could also be used to apply a layer of poly(p-xylylene) (e.g. Parylene) or other polymer.
  • Organic and biocompatible coatings such as silicone or polyurethane are also usable as a wear surface.
  • the ultrasonic transducer has a 1 inch diameter and a nominal 2 MHz resonance frequency. Each transducer can consume about 28 W of power for droplet trapping at a flow rate of 3 GPM. This power usage translates to an energy cost of 0.25 kW hr/ m 3 . This measure is an indication of the very low cost of energy of this technology. Desirably, each transducer is powered and controlled by its own amplifier. In other embodiments, the ultrasonic transducer uses a square crystal, for example with 1 "x1 " dimensions. Alternatively, the ultrasonic transducer can use a rectangular crystal, for example with 1 "x2.5" dimensions.
  • Power dissipation per transducer was 10 W per 1 "x1 " transducer cross-sectional area and per inch of acoustic standing wave span in order to get sufficient acoustic trapping forces.
  • each 1 "x1 " square transducer consumes 40 W.
  • the larger 1 "x2.5" rectangular transducer uses 100W in an intermediate scale system.
  • the array of three 1 "x1 " square transducers would consume a total of 120 W and the array of two 1 "x2.5” transducers would consume about 200 W.
  • Arrays of closely spaced transducers represent alternate potential embodiments of the technology. Transducer size, shape, number, and location can be varied as desired to generate desired three- dimensional acoustic standing wave patterns.
  • the size, shape, and thickness of the transducer determine the transducer displacement at different frequencies of excitation, which in turn affects separation efficiency.
  • the transducer is operated at frequencies near the thickness resonance frequency (half wavelength).
  • Gradients in transducer displacement typically result in more trapping locations for the cells/biomolecules.
  • Higher order modal displacements generate three-dimensional acoustic standing waves with strong gradients in the acoustic field in all directions, thereby creating equally strong acoustic radiation forces in all directions, leading to multiple trapping lines, where the number of trapping lines correlate with the particular mode shape of the transducer.
  • Figure 11 shows the measured electrical impedance amplitude of a square transducer as a function of frequency in the vicinity of the 2.2 MHz transducer resonance.
  • the minima in the transducer electrical impedance correspond to acoustic resonances of the water column and represent potential frequencies for operation.
  • Numerical modeling has indicated that the transducer displacement profile varies significantly at these acoustic resonance frequencies, and thereby directly affects the acoustic standing wave and resulting trapping force. Since the transducer operates near its thickness resonance, the displacements of the electrode surfaces are essentially out of phase. The typical displacement of the transducer electrodes is not uniform and varies depending on frequency of excitation.
  • the displacement has a single maximum in the middle of the electrode and minima near the transducer edges.
  • the transducer profile has multiple maxima leading to multiple trapped lines of oil droplets. Higher order transducer displacement patterns result in higher trapping forces and multiple stable trapping lines for the captured oil droplets.
  • Figure 13 is a numerical model showing a pressure field that matches the 9 trapping line pattern.
  • the numerical model is a two-dimensional model; and therefore only three trapping lines are observed. Two more sets of three trapping lines exist in the third dimension perpendicular to the plane of the page.
  • the system is operated at a voltage such that the particles (i.e. biomolecules or cells) are trapped in the ultrasonic standing wave, i.e., remain in a stationary position.
  • the particles are collected in along well defined trapping lines, separated by half a wavelength. Within each nodal plane, the particles are trapped in the minima of the acoustic radiation potential.
  • the axial component of the acoustic radiation force drives particles with a positive contrast factor to the pressure nodal planes, whereas particles with a negative contrast factor are driven to the pressure anti-nodal planes.
  • the radial or lateral component of the acoustic radiation force is the force that traps the particle.
  • the radial or lateral component of the acoustic radiation force is typically several orders of magnitude smaller than the axial component of the acoustic radiation force.
  • the lateral force generated by the transducers of the present disclosure can be significant, on the same order of magnitude as the axial force component, and is sufficient to overcome the fluid drag force at linear velocities of up to 1 cm/s.
  • the lateral force can be increased by driving the transducer in higher order mode shapes, as opposed to a form of vibration where the crystal effectively moves as a piston having a uniform displacement.
  • the acoustic pressure is proportional to the driving voltage of the transducer.
  • the electrical power is proportional to the square of the voltage.
  • the transducer is typically a thin piezoelectric plate, with electric field in the z-axis and primary displacement in the z-axis.
  • the transducer is typically coupled on one side by air (i.e. the air gap within the transducer) and on the other side by the fluid of the cell culture media.
  • the types of waves generated in the plate are known as composite waves.
  • a subset of composite waves in the piezoelectric plate is similar to leaky symmetric (also referred to as compressional or extensional) Lamb waves.
  • the piezoelectric nature of the plate typically results in the excitation of symmetric Lamb waves.
  • the waves are leaky because they radiate into the water layer, which result in the generation of the acoustic standing waves in the water layer.
  • Lamb waves exist in thin plates of infinite extent with stress free conditions on its surfaces. Because the transducers of this embodiment are finite in nature, the actual modal displacements are more complicated.
  • Figure 14 shows the typical variation of the in-plane displacement (x- displacement) and out-of-plane displacement (y-displacement) across the thickness of the plate, the in-plane displacement being an even function across the thickness of the plate and the out-of-plane displacement being an odd function. Because of the finite size of the plate, the displacement components vary across the width and length of the plate.
  • a (m,n) mode is a displacement mode of the transducer in which there are m undulations in transducer displacement in the width direction and n undulations in the length direction, and with the thickness variation as described in Figure 14.
  • the maximum number of m and n is a function of the dimension of the crystal and the frequency of excitation.
  • the transducers are driven so that the piezoelectric crystal vibrates in higher order modes of the general formula (m, n), where m and n are independently 1 or greater. Generally, the transducers will vibrate in higher order modes than (2,2). Higher order modes will produce more nodes and antinodes, result in three-dimensional standing waves in the fluid layer, characterized by strong gradients in the acoustic field in all directions, not only in the direction of the standing waves, but also in the lateral directions. As a consequence, the acoustic gradients result in stronger trapping forces in the lateral direction.
  • the pulsed voltage signal driving the transducer can have a sinusoidal, square, sawtooth, or triangle waveform; and have a frequency of 500 kHz to 10 MHz.
  • the pulsed voltage signal can be driven with pulse width modulation, which produces any desired waveform.
  • the pulsed voltage signal can also have amplitude or frequency modulation start/stop capability to eliminate streaming.
  • the transducer(s) is/are used to create a pressure field that generates forces of the same order of magnitude both orthogonal to the standing wave direction and in the standing wave direction.
  • forces are roughly the same order of magnitude, particles of size 0.1 microns to 300 microns will be moved more effectively towards regions of agglomeration ("trapping lines").
  • regions of agglomeration regions of agglomeration
  • hot spots are located in the maxima or minima of acoustic radiation potential. Such hot spots represent particle collection locations which allow for better wave transmission between the transducer and the reflector during collection and stronger inter-particle forces, leading to faster and better particle agglomeration.
  • Figure 15 and Figure 16 are exploded views showing the various parts of acoustophoretic separators.
  • Figure 15 has only one separation chamber, while Figure 16 has two separation chambers.
  • fluid enters the separator 190 through a four-port inlet 191.
  • a transition piece 192 is provided to create plug flow through the separation chamber 193.
  • a transducer 40 and a reflector 194 are located on opposite walls of the separation chamber. Fluid then exits the separation chamber 193 and the separator through outlet 195.
  • Figure 16 has two separation chambers 193. A system coupler 196 is placed between the two chambers 193 to join them together.
  • Acoustophoretic separation has been tested on different lines of Chinese hamster ovary (CHO) cells. In one experiment, a solution with a starting cell density of 8.09x 10 6 cells/mL, a turbidity of 1 ,232 NTU, and cell viability of roughly 75% was separated using a system as depicted in Figure 15. The transducers were 2 MHz crystals, run at approximately 2.23 MHz, drawing 24-28 Watts. A flow rate of 25 mL/min was used. The result of this experiment is shown in Figure 17.
  • Figure 17 and Figure 18 were produced by a Beckman Coulter Cell Viability Analyzer. Other tests revealed that frequencies of 1 MHz and 3 MHz were not as efficient as 2 MHz at separating the cells from the fluid.
  • all of the parts of the system e.g. the flow chamber, tubing leading to and from the bioreactor or filtering device, the sleeve containing the ultrasonic transducer and the reflector, the temperature-regulating jacket, etc.
  • the parts of the system can be separated from each other and be disposable. Avoiding centrifuges and filters allows better separation of the CHO cells without lowering the viability of the cells.
  • the transducers may also be driven to create rapid pressure changes to prevent or clear blockages due to agglomeration of CHO cells.
  • the frequency of the transducers may also be varied to obtain optimal effectiveness for a given power.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Clinical Laboratory Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Un bioréacteur à perfusion comprend au moins un transducteur ultrasonore qui peut générer par voie acoustique une onde stationnaire multidimensionnelle. L'onde stationnaire peut être utilisée pour retenir des cellules dans le bioréacteur et, également, pour déshydrater ou récolter davantage de produit depuis les déchets produits dans un bioréacteur.
EP16754152.3A 2016-08-16 2016-08-16 Bioréacteur utilisant des ondes stationnaires acoustiques Withdrawn EP3500659A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/047217 WO2018034655A1 (fr) 2016-08-16 2016-08-16 Bioréacteur utilisant des ondes stationnaires acoustiques

Publications (1)

Publication Number Publication Date
EP3500659A1 true EP3500659A1 (fr) 2019-06-26

Family

ID=56740583

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16754152.3A Withdrawn EP3500659A1 (fr) 2016-08-16 2016-08-16 Bioréacteur utilisant des ondes stationnaires acoustiques

Country Status (4)

Country Link
EP (1) EP3500659A1 (fr)
CN (1) CN109844089B (fr)
CA (1) CA3034208A1 (fr)
WO (1) WO2018034655A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US10975368B2 (en) 2014-01-08 2021-04-13 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US11420136B2 (en) 2016-10-19 2022-08-23 Flodesign Sonics, Inc. Affinity cell extraction by acoustics
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
KR102439221B1 (ko) 2017-12-14 2022-09-01 프로디자인 소닉스, 인크. 음향 트랜스듀서 구동기 및 제어기
ES2931873T3 (es) * 2018-12-11 2023-01-03 Aenitis Tech Sistema y método para cambiar una concentración de partículas en un fluido
CN111154648B (zh) * 2019-12-27 2022-10-25 新乡医学院三全学院 一种干细胞源性外泌体培养装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100820D0 (sv) * 2001-03-09 2001-03-09 Erysave Ab Ideon Particle separation using an acoustic filter
US9416344B2 (en) * 2012-03-15 2016-08-16 Flodesign Sonics, Inc. Bioreactor using acoustic standing waves
CN104334626A (zh) * 2012-03-16 2015-02-04 3M创新有限公司 轻质制品、复合组合物及其制备工艺
WO2014124306A1 (fr) * 2013-02-07 2014-08-14 Flodesign Sonics, Inc. Bioréacteur utilisant des ondes acoustiques stationnaires
WO2015102528A1 (fr) * 2013-12-30 2015-07-09 Ge Healthcare Bio-Sciences Corp. Dispositif de culture cellulaire
WO2016054192A1 (fr) * 2014-09-30 2016-04-07 Flodesign Sonics, Inc. Clarification acoustophorétique de fluides sans écoulement et chargés en particules

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US10975368B2 (en) 2014-01-08 2021-04-13 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis

Also Published As

Publication number Publication date
WO2018034655A1 (fr) 2018-02-22
CA3034208A1 (fr) 2018-02-22
CN109844089B (zh) 2022-08-23
CN109844089A (zh) 2019-06-04

Similar Documents

Publication Publication Date Title
US10662404B2 (en) Bioreactor using acoustic standing waves
US9783775B2 (en) Bioreactor using acoustic standing waves
US9752114B2 (en) Bioreactor using acoustic standing waves
CA2900277C (fr) Bioreacteur utilisant des ondes acoustiques stationnaires
US9416344B2 (en) Bioreactor using acoustic standing waves
CN109844089B (zh) 使用声驻波的生物反应器
US20170191022A1 (en) Bioreactor using acoustic standing waves
US10662402B2 (en) Acoustic perfusion devices
US9688958B2 (en) Acoustic bioreactor processes
EP3360955A1 (fr) Bioréacteur utilisant des ondes stationnaires acoustiques
EP3504314B1 (fr) Procédés acoustiques associés à des bioréacteurs
EP3019606B1 (fr) Procédés acoustiques associés à des bioréacteurs
US10689609B2 (en) Acoustic bioreactor processes
EP3234099B1 (fr) Dispositifs acoustiques de perfusion
EP3341463B1 (fr) Dispositifs de perfusion acoustiques

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190315

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KENNEDY, III, THOMAS J.

Inventor name: DIONNE, JASON

Inventor name: MERCADO, ARI

Inventor name: KOWALSKI, III, STANLEY

Inventor name: DUTRA, BRIAN

Inventor name: MASI, LOUIS

Inventor name: MARTIN, ARTHUR

Inventor name: LIPKENS, BART

Inventor name: PRESZ, JR., WALTER M.

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20230602